Skip to content
10-Q

Quarterly Report

Mineralys Therapeutics, Inc. MLYS

0001933414-25-000142

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 79.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 70.59M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 49.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.06M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $96K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$104.53M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$99.47M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $217.6M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $114.09M
Stockholders Equity Q3 2025 · Sep 30, 2025 $576.43M
Stockholders Equity Q3 2025 · Jun 30, 2025 $313.55M
Stockholders Equity Q3 2025 · Mar 31, 2025 $341.56M
Stockholders Equity Q3 2025 · Dec 31, 2024 $191.26M
Stockholders Equity Q3 2025 · Sep 30, 2024 $236.93M
Stockholders Equity Q3 2025 · Jun 30, 2024 $290.1M
Stockholders Equity Q3 2025 · Mar 31, 2024 $328.05M
Stockholders Equity Q3 2025 · Dec 31, 2023 $241.15M
Current Liabilities Q3 2025 · Sep 30, 2025 $23.52M
Current Liabilities Q3 2025 · Dec 31, 2024 $14.65M
Current Assets Q3 2025 · Sep 30, 2025 $599.8M
Current Assets Q3 2025 · Dec 31, 2024 $205.35M
Total Assets Q3 2025 · Sep 30, 2025 $599.95M
Total Assets Q3 2025 · Dec 31, 2024 $205.9M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.52
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.94
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.68
Eps Basic Q3 2025 · Sep 30, 2025 −$0.52
Eps Basic Q3 2025 · Sep 30, 2025 −$1.94
Eps Basic Q3 2025 · Sep 30, 2024 −$1.13
Eps Basic Q3 2025 · Sep 30, 2024 −$2.68
Sga Expense Q3 2025 · Sep 30, 2025 $9.68M
Sga Expense Q3 2025 · Sep 30, 2025 $24.72M
Sga Expense Q3 2025 · Sep 30, 2024 $6.12M
Sga Expense Q3 2025 · Sep 30, 2024 $16.62M
Rd Expense Q3 2025 · Sep 30, 2025 $31.45M
Rd Expense Q3 2025 · Sep 30, 2025 $107.61M
Rd Expense Q3 2025 · Sep 30, 2024 $53.99M
Rd Expense Q3 2025 · Sep 30, 2024 $124.01M
Net Income Q3 2025 · Sep 30, 2025 −$36.93M
Net Income Q3 2025 · Sep 30, 2025 −$122.42M
Net Income Q3 2025 · Jun 30, 2025 −$43.27M
Net Income Q3 2025 · Mar 31, 2025 −$42.21M
Net Income Q3 2025 · Sep 30, 2024 −$56.34M
Net Income Q3 2025 · Sep 30, 2024 −$128.86M
Net Income Q3 2025 · Jun 30, 2024 −$41.01M
Net Income Q3 2025 · Mar 31, 2024 −$31.51M
Operating Income Q3 2025 · Sep 30, 2025 −$41.13M
Operating Income Q3 2025 · Sep 30, 2025 −$132.32M
Operating Income Q3 2025 · Sep 30, 2024 −$60.11M
Operating Income Q3 2025 · Sep 30, 2024 −$140.64M